Listen

Add to my selection

ROZLYTREK (entrectinib)

Medicine - Posted on Aug 26 2021

Active substance (DCI)

entrectinib

history (2)

7/21/21

ROZLYTREK (entrectinib) (CPNPC)

Key points Unfavourable opinion for reimbursement in the treatment of adult patients with ROS1-positive (ROS1+), advanced no...

CAV :
54321

icône flèche
7/21/21

ROZLYTREK (entrectinib) (tumeurs solides)

Key points Unfavourable opinion for reimbursement in adult and paediatric patients 12 years of age and older with solid tumo...

CAV :
54321

icône flèche

Technical information

ATC code

L01XE56

Manufacturer

ROCHE

Presentation

ROZLYTREK 100 mg, gélule
Boîte de 30 gélules - (Code CIP : 34009 302 129 9 8)

ROZLYTREK 200 mg, gélule
Boîte de 90 gélules - (Code CIP : 34009 302 130 1 8)

All our publications

Cancers - miscellaneous

Respiratory tract cancers